// App-Quantinova.ai

POS04 : Safety and efficacy of everolimus-eluting bioresorbable scaffolds in complex coronary lesions

Researchers

Presenter

  • De Waha S

Principal Investigators

  • El-Mawardy M

  • Sato T

  • Sulimov D

  • Toelg R

  • Abdel-Wahab M

  • Richardt G

Medical Centers

  • Heart Centre Bad Segeberg, Bad Segeberg, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Coronary Artery Disease

  • Myocardial infarction

  • Venous thrombosis

  • Diabetes

Biomarkers

  • Acetyl-CoA carboxylase

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved